These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 8430203)
1. Advantages of CT and beam's eye view display to confirm the accuracy of pelvic lymph node irradiation in carcinoma of the prostate. Forman JD; Lee Y; Roberson P; Montie JE; Zingas AP; Porter AT Radiology; 1993 Mar; 186(3):889-92. PubMed ID: 8430203 [TBL] [Abstract][Full Text] [Related]
3. Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. Shih HA; Harisinghani M; Zietman AL; Wolfgang JA; Saksena M; Weissleder R Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1262-9. PubMed ID: 16253781 [TBL] [Abstract][Full Text] [Related]
4. Distribution of lymph nodes in men with prostatic adenocarcinoma and lymphadenopathy at presentation: a retrospective radiological review and implications for prostate and pelvis radiotherapy. Jackson AS; Sohaib SA; Staffurth JN; Huddart RA; Parker CC; Horwich A; Dearnaley DP Clin Oncol (R Coll Radiol); 2006 Mar; 18(2):109-16. PubMed ID: 16523810 [TBL] [Abstract][Full Text] [Related]
5. RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Lawton CA; Michalski J; El-Naqa I; Buyyounouski MK; Lee WR; Menard C; O'Meara E; Rosenthal SA; Ritter M; Seider M Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):383-7. PubMed ID: 18947938 [TBL] [Abstract][Full Text] [Related]
6. Pelvic lymph node irradiation for prostate cancer: who, why, and when? Wang D; Lawton C Semin Radiat Oncol; 2008 Jan; 18(1):35-40. PubMed ID: 18082586 [TBL] [Abstract][Full Text] [Related]
7. Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer. Lawton CA; Michalski J; El-Naqa I; Kuban D; Lee WR; Rosenthal SA; Zietman A; Sandler H; Shipley W; Ritter M; Valicenti R; Catton C; Roach M; Pisansky TM; Seider M Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):377-82. PubMed ID: 18947941 [TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer. Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444 [TBL] [Abstract][Full Text] [Related]
9. Analysis of localization errors in the definition of the mantle field using a beam's eye view treatment-planning system. Naida JD; Eisbruch A; Schoeppel SL; Sandler HM; Turrisi AT; Lichter AS Int J Radiat Oncol Biol Phys; 1996 May; 35(2):377-82. PubMed ID: 8635947 [TBL] [Abstract][Full Text] [Related]
10. Lymphatic drainage and CTV in carcinoma of the prostate. Cellini N; Luzi S; Mantini G; Mattiucci GC; Morganti AG; Digesù C; Bavasso A; Deodato F; Smaniotto D; Valentini V Rays; 2003; 28(3):337-41. PubMed ID: 15018322 [TBL] [Abstract][Full Text] [Related]
11. Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition. Ganswindt U; Paulsen F; Corvin S; Eichhorn K; Glocker S; Hundt I; Birkner M; Alber M; Anastasiadis A; Stenzl A; Bares R; Budach W; Bamberg M; Belka C BMC Cancer; 2005 Jul; 5():91. PubMed ID: 16048656 [TBL] [Abstract][Full Text] [Related]
15. Interindividual variability of lymph drainages in patients with cervical cancer. Implication on irradiation planning. Marnitz S; Köhler C; Schneider A; Seiler F; Hinkelbein W Strahlenther Onkol; 2006 Feb; 182(2):80-5. PubMed ID: 16447014 [TBL] [Abstract][Full Text] [Related]
16. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study. Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520 [TBL] [Abstract][Full Text] [Related]
17. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy. Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815 [TBL] [Abstract][Full Text] [Related]
18. Nodal Clearance Rate and Long-Term Efficacy of Individualized Sentinel Node-Based Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate Cancer. Müller AC; Eckert F; Paulsen F; Zips D; Stenzl A; Schilling D; Alber M; Bares R; Martus P; Weckermann D; Belka C; Ganswindt U Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):263-71. PubMed ID: 26853335 [TBL] [Abstract][Full Text] [Related]
19. Axillary lymph node dose with tangential breast irradiation. Reed DR; Lindsley SK; Mann GN; Austin-Seymour M; Korssjoen T; Anderson BO; Moe R Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):358-64. PubMed ID: 15667953 [TBL] [Abstract][Full Text] [Related]
20. Boost treatment of the prostate using shaped, fixed fields. Ten Haken RK; Perez-Tamayo C; Tesser RJ; McShan DL; Fraass BA; Lichter AS Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):193-200. PubMed ID: 2492268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]